Yamamoto K R, Stampfer M R, Tomkins G M
Proc Natl Acad Sci U S A. 1974 Oct;71(10):3901-5. doi: 10.1073/pnas.71.10.3901.
Mouse lymphoma tissue culture cells (S49.1A) are normally killed by dexamethasone, a synthetic glucocorticoid hormone. Dexamethasone-resistant clones have been selected from this line, some of which retain the ability to specifically bind dexamethasone. Addition of [(3)H]dexamethasone to cultures, followed by cell fractionation, reveals that the nuclear transfer of hormone-receptor complexes in some of these variant clones is deficient (nt(-)), while others show increased nuclear transfer (nt(i)) relative to the parental line. Two independently selected members of each class have been studied here, in an effort to elucidate the molecular determinants involved in the receptor-nucleus interaction in vivo. The labeled receptors in cell-free extracts bind to DNA-cellulose, but only after previous incubation of the extract at 20 degrees , similar to the treatment required for cell-free interaction of receptors with nuclei. More importantly, the apparent DNA-binding affinity of the nt(-) receptors is lower than the wild type, whereas the nt(i) receptors bind DNA with an affinity higher than the parental molecules. The parallelism of nuclear and DNA binding, together with the observations that the receptors from the variants have sedimentation properties different from the wild-type cells, lead us to conclude that (i) these variants may contain altered receptor molecules and (ii) DNA is probably the primary nuclear binding site for steroid receptors in vivo.
小鼠淋巴瘤组织培养细胞(S49.1A)通常会被地塞米松杀死,地塞米松是一种合成糖皮质激素。已从该细胞系中筛选出对地塞米松耐药的克隆,其中一些克隆仍保留特异性结合地塞米松的能力。向培养物中加入[³H]地塞米松,随后进行细胞分级分离,结果显示,这些变异克隆中的一些克隆中激素-受体复合物的核转运存在缺陷(nt(-)),而另一些克隆相对于亲代细胞系则表现出核转运增加(nt(i))。此处研究了每一类中的两个独立筛选出的成员,以阐明体内受体-细胞核相互作用中涉及的分子决定因素。无细胞提取物中的标记受体可与DNA纤维素结合,但前提是提取物要先在20℃下孵育,这与受体与细胞核进行无细胞相互作用所需的处理类似。更重要的是,nt(-)受体的表观DNA结合亲和力低于野生型,而nt(i)受体与DNA结合的亲和力高于亲代分子。核结合与DNA结合的平行关系,以及变异体的受体具有与野生型细胞不同的沉降特性这一观察结果,使我们得出以下结论:(i)这些变异体可能含有改变的受体分子;(ii)DNA可能是体内类固醇受体的主要核结合位点。